Abstract/Scope of Chapter
The aberrations in B-cell growth signaling that characterize aggressive B-cell lymphomas, including large B-cell lymphoma and mantle cell lymphoma, are discussed. The shift from paracrine to autocrine growth factor expression and the subsequent dysregulation of multiple ligand-receptor pathways are highlighted.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008;112:1570-80.
Monroe JG, Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development. Adv Immunol 2007;95:1-50.
Lin-Lee YC, Pham LV, Tamayo AT, et al. Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J Biol Chem 2006;281:18878-87.
Zhou HJ, Pham LV, Tamayo AT, et al. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. Blood 2007;110:2121-7.
Gilmore TD. Multiple myeloma: lusting for NF-kappaB. Cancer Cell 2007;12:95-7.
Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 2003;44(Suppl 3):S41-7.
Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2003;100:9991-6.
Pham LV, Tamayo AT, Yoshimura LC, Lin-Lee YC, Ford RJ. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005;106:3940-7.
Pham L, Tamayo A, Zhou H, et al. Networking modules of canonical and alternative NF-kB signaling in growth and survival regulations of large B cell lymphomas. Blood 2008:3776.
Homig-Holzel C, Hojer C, Rastelli J, et al. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med 2008;205:1317-29.
Sagaert X, De Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand? Leukemia 2007;21:389-96.
Jost PJ, Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007;109:2700-7.
Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J. Recurring chromosomal abnormalities in non-Hodgkin’s lymphoma: biologic and clinical significance. Semin Hematol 2000;37:396-411.
Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-9.
Vanasse GJ, Halbrook J, Thomas S, et al. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J Clin Invest 1999;103:1669-75.
Seto M. Genetic and epigenetic factors involved in B-cell lymphomagenesis. Cancer Sci 2004;95:704-10.
Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 1999;25:123-33.
Bastard C, Tilly H, Lenormand B, et al. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin’s lymphoma. Blood 1992;79:2527-31.
Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994;331:74-80.
Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992;80:758-67.
Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92:234-40.
Eisenman RN. Deconstructing myc. Genes Dev 2001;15:2023-30.
Pham L, Tamayo A, Zhou H, LIn-Lee Y, Fu L, Ford R. Recruitment of the SWI/SNF chromatin remodeling complex by NFATc1 in the transcriptional regulation of the C-MYC oncogene in aggressive B-cell lymphomas. Blood 2008:3808.
Kurtova A, Tamayo A, Ford R, Burger J. Migratory activity and stromal cell adhesion of mantle cell lymphoma cells can be diminished by blocking of VLA-4 and CXCR4 receptors. Blood 2008:3781.
Bryant J, Pham L, Yoshimura L, Tamayo A, Ordonez N, Ford RJ. Development of intermediate-grade (mantle cell) and low-grade (small lymphocytic and marginal zone) human non-Hodgkin’s lymphomas xenotransplanted in severe combined immunodeficiency mouse models. Lab Invest 2000;80:557-73.
Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008;111:3701-13.
Amin HM, McDonnell TJ, Medeiros LJ, et al. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 2003;127:424-31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pham, L.V., Ford, R.J. (2010). Growth Signaling and Survival Pathways in Aggressive B-cell Lymphoma. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_34
Download citation
DOI: https://doi.org/10.1007/978-1-60761-384-8_34
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-383-1
Online ISBN: 978-1-60761-384-8
eBook Packages: MedicineMedicine (R0)